Recordati Industria Chimica E Farmaceutica S.P.A. (RCDTF)
(Delayed Data from OTC)
$52.25 USD
0.00 (0.00%)
Updated Aug 1, 2024 02:00 PM ET
NA Value
NA Growth NA Momentum NA VGMCash flow Statements
Fiscal Year End for Recordati Industria Chimica E Farmaceutica SPA falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 421.25 | 329.08 | 456.64 | 405.55 | 413.13 |
Depreciation/Amortization & Depletion | 154.41 | 132.50 | 115.45 | 107.00 | 87.64 |
Net Change from Assets/Liabilities | -18.42 | -7.85 | 112.21 | 18.31 | -146.31 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -31.97 | 32.71 | -102.63 | 5.57 | 19.66 |
Net Cash From Operating Activities | 525.26 | 486.44 | 581.67 | 461.00 | 374.11 |
Property & Equipment | -31.77 | -23.95 | -25.66 | -24.29 | -35.02 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -709.35 | -0.36 | 0.00 | 0.00 |
Investments | 3.25 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -382.33 | -74.95 | -77.50 | -126.13 | -490.27 |
Net Cash from Investing Activities | -410.86 | -808.24 | -103.52 | -150.28 | -525.29 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 7.99 | -40.69 | -70.17 | -13.90 | 29.33 |
Issuance (Repayment) of Debt | 72.92 | 583.09 | -82.20 | -35.88 | 335.90 |
Increase (Decrease) Short-Term Debt | 2.47 | 60.13 | -10.83 | -11.11 | -11.59 |
Payment of Dividends & Other Distributions | -266.20 | -242.96 | -256.43 | -242.99 | -213.83 |
Other Financing Activities | 0.00 | 0.00 | -1.49 | 0.00 | 0.22 |
Net Cash from Financing Activities | -182.82 | 359.57 | -421.12 | -301.90 | 140.03 |
Effect of Exchange Rate Changes | 0.31 | 4.54 | 9.63 | -8.48 | 3.76 |
Net Change In Cash & Equivalents | -68.10 | 42.31 | 66.67 | 0.35 | -7.39 |
Cash at Beginning of Period | 308.17 | 257.69 | 222.69 | 214.66 | 202.87 |
Cash at End of Period | 240.07 | 300.00 | 289.36 | 215.02 | 195.47 |
Diluted Net EPS | 2.01 | 1.57 | 2.18 | 1.94 | 1.98 |
Fiscal Year End for Recordati Industria Chimica E Farmaceutica SPA falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | NA | 134.19 | 421.25 | 331.41 |
Depreciation/Amortization & Depletion | NA | NA | 43.42 | 154.41 | 113.06 |
Net Change from Assets/Liabilities | NA | NA | -3.00 | -18.42 | -43.66 |
Net Cash from Discontinued Operations | NA | NA | 0.00 | 0.00 | NA |
Other Operating Activities | NA | NA | -10.61 | -31.97 | 44.94 |
Net Cash From Operating Activities | NA | NA | 163.99 | 525.26 | 445.75 |
Property & Equipment | NA | NA | -4.27 | -31.77 | -19.23 |
Acquisition/ Disposition of Subsidiaries | NA | NA | 0.00 | 0.00 | NA |
Investments | NA | NA | 0.00 | 3.25 | NA |
Other Investing Activities | NA | NA | -4.50 | -382.33 | -372.57 |
Net Cash from Investing Activities | NA | NA | -8.77 | -410.86 | -391.80 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | NA | 4.95 | 8.00 | 14.36 |
Issuance (Repayment) of Debt | NA | NA | -7.76 | 72.92 | 145.36 |
Increase (Decrease) Short-Term Debt | NA | NA | -74.47 | 2.47 | -57.82 |
Payment of Dividends & Other Distributions | NA | NA | -0.74 | -266.20 | -140.48 |
Other Financing Activities | NA | NA | 0.00 | 0.00 | NA |
Net Cash from Financing Activities | NA | NA | -78.02 | -182.82 | -38.58 |
Effect of Exchange Rate Changes | NA | NA | 1.88 | 0.32 | 3.72 |
Net Change In Cash & Equivalents | NA | NA | 79.08 | -68.10 | 19.10 |
Cash at Beginning of Period | NA | NA | 240.82 | 308.17 | 309.90 |
Cash at End of Period | NA | NA | 319.90 | 240.07 | 329.00 |
Diluted Net EPS | NA | 0.52 | 0.64 | 0.44 | 0.40 |